Fig. 1: Childhood and adolescence lipid and insulin levels in participants who later developed schizophrenia, any non-affective psychosis and controls.
From: Metabolic trajectories in childhood and adolescence: Effects on risk for schizophrenia
Mean (95% CI) fasting plasma insulin*, total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglyceride* levels in children and adolescents (9–18 years of age) who later developed A schizophreniaa or B any non-affective psychosisb and controls. Gray dashed line = individuals who later developed schizophrenia, gray dash-dotted line = individuals who later developed any non-affective psychosis and black solid line = controls with no psychiatric diagnoses during the follow-up 1980–2018. *geometric means. aDSM-IV diagnosis 295. bDSM-IV diagnoses 295, 297, and 298.
